SP426HYPOGLYCAEMIC EPISODES EVALUATED BY CONTINUOUS GLUCOSE MONITORING IN PATIENTS WITH TYPE 2 DIABETES AND DIALYSIS-DEPENDENT END-STAGE RENAL DISEASE RANDOMISED TO 12-WEEK LIRAGLUTIDE OR PLACEBO TREATMENT. (18th May 2018) - Bomholt, Tobias; Idorn, Thomas; Knop, Filip K; Jørgensen, Morten B; Resuli, Marsela; Christensen, Karl B; Hansen, Pernille M; Borg, Rikke; Persson, Frederik; Feldt-Rasmussen, Bo; Hornum, Mads